Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis

Results from the STREAM stage 1 trial showed that a 9-month regimen for patients with rifampicin-resistant tuberculosis was non-inferior to the 20-month regimen recommended by the 2011 WHO treatment guidelines. Similar levels of severe adverse events were reported on both regimens suggesting the nee...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodall, Ruth L., Sanders, Karen, Bronson, Gay, Gurumurthy, Meera, Torrea, Gabriela, Meredith, Sarah, Nunn, Andrew, Rusen, I. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171092/
https://www.ncbi.nlm.nih.gov/pubmed/35672833
http://dx.doi.org/10.1186/s13063-022-06397-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171092/
https://www.ncbi.nlm.nih.gov/pubmed/35672833
http://dx.doi.org/10.1186/s13063-022-06397-4

Ejemplares similares